Growth Arrest of BCR-ABL Positive Cells with a Sequence-Specific Polyamide-Chlorambucil Conjugate
C. James Chou, Thomas O'Hare, Sophie Lefebvre et al. · 2008
Read Growth Arrest of BCR-ABL Positive Cells with a Sequence-Specific Polyamide-Chlorambucil Conjugate by C. James Chou, Thomas O'Hare, Sophie Lefebvre et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0003593.txt.
Description
C. James Chou and co-authors built a targeted drug for leukemia cells in this 2008 paper. Chronic myeloid leukemia is marked by the BCR-ABL fusion gene. That gene, born of the Philadelphia chromosome swap, makes an always-on kinase. Imatinib already blocks that kinase, but resistance can arise.
The team fused a sequence-specific polyamide to chlorambucil, a cell-killing drug. The conjugate arrested the growth of BCR-ABL positive cells. Guiding a poison to one DNA address is the core idea. Such targeting could spare cells lacking the fusion gene. The fusion gene is found in nearly all cases of this leukemia type.
Catalog record
| CREATOR | C. James Chou, Thomas O'Hare, Sophie Lefebvre et al. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0003593